This is a study to evaluate the efficacy and safety of TQB2450 injection combination with Intensity-modulated Radiotherapy in patients with inoperable locally recurrent nasopharyngeal carcinoma.
| Condition | Advanced Malignancies, Carcinoma, nasopharyngeal carcinoma, Nasopharyngeal Cancer, Vulvar Dysplasia and Carcinoma |
|---|---|
| Treatment | Intensity Modulated Radiotherapy, TQB2450 |
| Clinical Study Identifier | NCT04895345 |
| Sponsor | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Last Modified on | 12 September 2023 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.